Tian'an Technology (TANAF) Equity Ratio (2022 - 2025)

Tian'an Technology's (TANAF) quarterly Equity Ratio came in at 0.12 in Q4 2025, down 729.53% year-on-year from 0.02 in Q4 2024, and down 729.53% quarter-over-quarter from 0.02 in Q4 2024.

Tian'an Technology (TANAF) Equity Ratio (2022 - 2025) Analysis & Trends

Tian'an Technology has disclosed Equity Ratio across 4 years of filings, most recently posting 0.12 for Q4 2025.

  • Equity Ratio for Q4 2025 came in at 0.12, down 729.53% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.12 (down 729.53% YoY), and the FY2025 annual result was 0.12, down 729.53% from the prior year.
  • Equity Ratio came in at 0.12 for Q4 2025 at Tian'an Technology, down from 0.02 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.02 in Q4 2024 to a low of 4.12 in Q4 2022.
  • The 4-year median for Equity Ratio is 1.6 (2023), against an average of 1.82.
  • Across the five-year window, Equity Ratio jumped 100.64% in 2024 and tumbled 729.53% in 2025, its largest moves.
  • Tian'an Technology's Equity Ratio stood at 4.12 in 2022, then increased by 25.44% to 3.07 in 2023, then surged by 100.64% to 0.02 in 2024, then sank by 729.53% to 0.12 in 2025.
  • The last three Equity Ratio figures came in at 0.12 (Q4 2025), 0.02 (Q4 2024), and 3.07 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 0.47
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 0.50
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 0.54
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 0.59
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 0.78
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.42
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 0.45
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 0.29
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 0.67
10 Tian'an Technology - - - -0.12

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.12
Dec 31, 2024 0.02
Dec 31, 2023 -3.07
Dec 31, 2022 -4.12